237 results
Page 9 of 12
6-K
EX-99
kcg6 eobnz
17 Sep 14
Current report (foreign)
12:00am
6-K
EX-99
6zp283j24qgwr
3 Sep 14
Current report (foreign)
12:00am
6-K
EX-99
cm6 u82hay1yx16
21 Aug 14
BioLineRx Receives Notice of Allowance for US Patent on BL-7010
12:00am
6-K
EX-99
i2hx9tr2 96t
6 Aug 14
BioLineRx Reports Second Quarter 2014 Financial Results
12:00am
6-K
EX-99
j4c49dwm 005p
16 Jul 14
BioLineRx Announces Results from
12:00am
6-K
EX-1
xjxam3ktyc9a1lnq7ogu
23 Jun 14
Current report (foreign)
12:00am
6-K
EX-99
jdswvqsf4k8j2m9
16 Jun 14
BioLineRx Receives Approval to Commence
12:00am
424B2
sng082q9a fs
13 Jun 14
Prospectus for primary offering
12:00am
6-K
EX-1
844oc492 jvg2086q
11 Jun 14
Current report (foreign)
12:00am
F-3
vfgrtenfal8k a2
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-99.1
3ji40mkt9
30 May 14
Current report (foreign)
12:00am
6-K
EX-99
nxpboyqvv1ih2 xkd
20 May 14
BioLineRx Reports First Quarter 2014 Financial Results
12:00am
6-K
EX-99
o3w2v2iol 84n
10 Apr 14
Current report (foreign)
12:00am
6-K
EX-99
eaopjg28l5zu3
17 Mar 14
BioLineRx Reports Year End 2013 Financial Results
12:00am
6-K
EX-99
s6dpbil clak
14 Mar 14
BioLineRx Announces Issuance of United States Patent
12:00am
6-K
EX-99
xbbb8q6j
10 Mar 14
BioLineRx Completes Dose Escalation Stage of Phase 1/2 Study
12:00am
6-K
EX-99.1
viymr c4amrzex
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
6-K
EX-1.1
jmxk1r5v 2b4c1j
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am